Basel, Switzerland

Elisabeth Schaible

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Elisabeth Schaible

Introduction

Elisabeth Schaible is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative designs in syringe technology. Her work has the potential to enhance the delivery of medications, ensuring better patient outcomes.

Latest Patents

Elisabeth Schaible holds a patent for a syringe and method of preparing a syringe. This syringe features a longitudinal body with an interior designed to hold a pharmaceutical substance. It includes a needle connected to one end of the body and a rigid needle shield that encases the needle. The rigid needle shield is water vapor tight, which helps prevent needle clogging. This innovation is particularly beneficial for the proper provision of pharmaceuticals through subcutaneous, intramuscular, or ocular injection.

Career Highlights

Throughout her career, Elisabeth has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Genentech, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical technology.

Collaborations

Elisabeth has collaborated with notable professionals in her field, including Frank Bamberg and Heather L. Flores. These partnerships have fostered an environment of creativity and innovation, leading to the development of her patented syringe technology.

Conclusion

Elisabeth Schaible's contributions to syringe technology exemplify her commitment to improving pharmaceutical delivery systems. Her innovative designs and collaborations with industry leaders highlight her role as a significant figure in the field of medical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…